Skip to main content
logo
InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
20.16
-1.09 (-5.13%)
At close: Jul 31, 2026

InventisBio Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.6437.29168.79185.53--
Revenue Growth
-57.45%-77.91%-9.02%---
Gross Profit
66.1532.27164.87185.53--
Operating Income
-336.94-351.49-280.95-327.65-519.44-362.8
Net Income
-303.73-316.87-240.2-283.98-483.49-357.91
Earnings Per Share
-0.53-0.55-0.42-0.49-0.95-0.78
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3781,5351,6871,9192,235724.25
Total Debt
19.9722.0723.9211.6227.3423.66
Net Cash (Debt)
1,3581,5131,6631,9082,208700.6
Net Cash Growth
-15.65%-9.06%-12.82%-13.59%215.14%-32.20%
Net Cash Per Share
2.382.632.913.324.341.53

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-236.05-155.44-241.97-307.75-476.89-252.07
Capital Expenditures
-6.18-6.92-7.56-6.29-7.69-26.52
Free Cash Flow
-242.22-162.36-249.53-314.04-484.59-278.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.33%86.54%97.67%100.00%--
Operating Margin
-470.31%-942.59%-166.45%-176.61%--
Pretax Margin
-423.47%-849.10%-142.31%-153.06%--
Profit Margin
-423.95%-849.74%-142.31%-153.06%--
FCF Margin
-338.10%-435.41%-147.84%-169.27%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
162.74422.4845.4546.92--